<unk>  is thought to have clinically negligible inhibitory effects on the cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2D6, CYP2C8, CYP2C9, and CYP2C19. As a result, it is thought that drug interactions of<unk>  with cytochrome P450 substrates are unlikely. No clinically significant drug interactions have been reported with<unk>  as of 2003.<unk>  does not affect circulating levels of tamoxifen or its major metabolite N-desmethyltamoxifen. However, tamoxifen has been found to decrease steady-state area-under-the-curve levels of<unk>  by 27%. But estradiol levels were not significantly different in the group that received both<unk>  and tamoxifen compared to the<unk>  alone group, so the decrease in<unk>  levels is not thought to be clinically important.
Anastrozole
Tamoxifen
Letrozole
Endoxifen
Salvestrol
Norendoxifen
Goserelin
N-Desmethyltamoxifen